Logo image of UNH

UNITEDHEALTH GROUP INC (UNH) Stock Fundamental Analysis

NYSE:UNH - New York Stock Exchange, Inc. - US91324P1021 - Common Stock - Currency: USD

306.795  -4.52 (-1.45%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to UNH. UNH was compared to 102 industry peers in the Health Care Providers & Services industry. While UNH is still in line with the averages on profitability rating, there are concerns on its financial health. UNH may be a bit undervalued, certainly considering the very reasonable score on growth UNH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

UNH had positive earnings in the past year.
In the past year UNH had a positive cash flow from operations.
In the past 5 years UNH has always been profitable.
Each year in the past 5 years UNH had a positive operating cash flow.
UNH Yearly Net Income VS EBIT VS OCF VS FCFUNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

1.2 Ratios

UNH has a Return On Assets of 7.14%. This is amongst the best in the industry. UNH outperforms 87.25% of its industry peers.
The Return On Equity of UNH (21.93%) is better than 89.22% of its industry peers.
With a decent Return On Invested Capital value of 8.68%, UNH is doing good in the industry, outperforming 77.45% of the companies in the same industry.
UNH had an Average Return On Invested Capital over the past 3 years of 10.14%. This is in line with the industry average of 9.62%.
Industry RankSector Rank
ROA 7.14%
ROE 21.93%
ROIC 8.68%
ROA(3y)7.06%
ROA(5y)7.43%
ROE(3y)22.21%
ROE(5y)22.85%
ROIC(3y)10.14%
ROIC(5y)10.16%
UNH Yearly ROA, ROE, ROICUNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

UNH has a Profit Margin of 5.39%. This is in the better half of the industry: UNH outperforms 78.43% of its industry peers.
UNH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.16%, UNH is in the better half of the industry, outperforming 74.51% of the companies in the same industry.
UNH's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.16%
PM (TTM) 5.39%
GM N/A
OM growth 3Y-1.09%
OM growth 5Y-0.16%
PM growth 3Y-15.71%
PM growth 5Y-8.84%
GM growth 3YN/A
GM growth 5YN/A
UNH Yearly Profit, Operating, Gross MarginsUNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UNH is creating some value.
UNH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, UNH has less shares outstanding
The debt/assets ratio for UNH is higher compared to a year ago.
UNH Yearly Shares OutstandingUNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
UNH Yearly Total Debt VS Total AssetsUNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

UNH has a debt to FCF ratio of 3.31. This is a good value and a sign of high solvency as UNH would need 3.31 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.31, UNH is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
UNH has a Debt/Equity ratio of 0.71. This is a neutral value indicating UNH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.71, UNH perfoms like the industry average, outperforming 51.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 3.31
Altman-Z N/A
ROIC/WACC1.06
WACC8.16%
UNH Yearly LT Debt VS Equity VS FCFUNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

UNH has a Current Ratio of 0.88. This is a bad value and indicates that UNH is not financially healthy enough and could expect problems in meeting its short term obligations.
UNH has a Current ratio of 0.88. This is in the lower half of the industry: UNH underperforms 74.51% of its industry peers.
A Quick Ratio of 0.88 indicates that UNH may have some problems paying its short term obligations.
The Quick ratio of UNH (0.88) is worse than 68.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
UNH Yearly Current Assets VS Current LiabilitesUNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.46% over the past year.
Measured over the past years, UNH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.07% on average per year.
Looking at the last year, UNH shows a quite strong growth in Revenue. The Revenue has grown by 8.06% in the last year.
UNH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.57% yearly.
EPS 1Y (TTM)7.46%
EPS 3Y13.67%
EPS 5Y13.07%
EPS Q2Q%0.56%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y11.65%
Revenue growth 5Y10.57%
Sales Q2Q%9.49%

3.2 Future

UNH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.37% yearly.
Based on estimates for the next years, UNH will show a quite strong growth in Revenue. The Revenue will grow by 8.02% on average per year.
EPS Next Y-12.93%
EPS Next 2Y0.03%
EPS Next 3Y4.28%
EPS Next 5Y8.37%
Revenue Next Year12.32%
Revenue Next 2Y9.49%
Revenue Next 3Y8.71%
Revenue Next 5Y8.02%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UNH Yearly Revenue VS EstimatesUNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200B 400B 600B
UNH Yearly EPS VS EstimatesUNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40 50

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.97, which indicates a very decent valuation of UNH.
UNH's Price/Earnings ratio is rather cheap when compared to the industry. UNH is cheaper than 88.24% of the companies in the same industry.
UNH is valuated cheaply when we compare the Price/Earnings ratio to 26.32, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 10.98, the valuation of UNH can be described as very reasonable.
Based on the Price/Forward Earnings ratio, UNH is valued cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of UNH to the average of the S&P500 Index (22.13), we can say UNH is valued rather cheaply.
Industry RankSector Rank
PE 10.97
Fwd PE 10.98
UNH Price Earnings VS Forward Price EarningsUNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UNH indicates a somewhat cheap valuation: UNH is cheaper than 73.53% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, UNH is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.34
EV/EBITDA 8.8
UNH Per share dataUNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

UNH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.84
EPS Next 2Y0.03%
EPS Next 3Y4.28%

7

5. Dividend

5.1 Amount

UNH has a Yearly Dividend Yield of 2.78%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of UNH has falen by -35.84%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
UNH's Dividend Yield is rather good when compared to the industry average which is at 2.41. UNH pays more dividend than 94.12% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, UNH has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

On average, the dividend of UNH grows each year by 14.73%, which is quite nice.
UNH has been paying a dividend for at least 10 years, so it has a reliable track record.
UNH has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)14.73%
Div Incr Years15
Div Non Decr Years34
UNH Yearly Dividends per shareUNH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

34.90% of the earnings are spent on dividend by UNH. This is a low number and sustainable payout ratio.
The dividend of UNH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.9%
EPS Next 2Y0.03%
EPS Next 3Y4.28%
UNH Yearly Income VS Free CF VS DividendUNH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B
UNH Dividend Payout.UNH Dividend Payout, showing the Payout Ratio.UNH Dividend Payout.PayoutRetained Earnings

UNITEDHEALTH GROUP INC

NYSE:UNH (6/16/2025, 2:42:08 PM)

306.795

-4.52 (-1.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-17 2025-04-17/bmo
Earnings (Next)07-29 2025-07-29/amc
Inst Owners91.04%
Inst Owner Change1.58%
Ins Owners0.19%
Ins Owner Change3.04%
Market Cap278.31B
Analysts77.5
Price Target402.69 (31.26%)
Short Float %1.23%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend8.19
Dividend Growth(5Y)14.73%
DP34.9%
Div Incr Years15
Div Non Decr Years34
Ex-Date06-16 2025-06-16 (2.21)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.94%
Min EPS beat(2)-2.18%
Max EPS beat(2)0.29%
EPS beat(4)3
Avg EPS beat(4)0.08%
Min EPS beat(4)-2.18%
Max EPS beat(4)1.12%
EPS beat(8)7
Avg EPS beat(8)1.73%
EPS beat(12)11
Avg EPS beat(12)2.42%
EPS beat(16)15
Avg EPS beat(16)2.48%
Revenue beat(2)0
Avg Revenue beat(2)-2.35%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-1.92%
Revenue beat(4)1
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)0.55%
Revenue beat(8)4
Avg Revenue beat(8)-0.32%
Revenue beat(12)5
Avg Revenue beat(12)-0.22%
Revenue beat(16)9
Avg Revenue beat(16)0.04%
PT rev (1m)-28.21%
PT rev (3m)-38.25%
EPS NQ rev (1m)-7.97%
EPS NQ rev (3m)-32.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.04%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 10.97
Fwd PE 10.98
P/S 0.68
P/FCF 11.34
P/OCF 9.87
P/B 2.76
P/tB 2.76
EV/EBITDA 8.8
EPS(TTM)27.96
EY9.11%
EPS(NY)27.93
Fwd EY9.11%
FCF(TTM)27.07
FCFY8.82%
OCF(TTM)31.09
OCFY10.13%
SpS452.03
BVpS111.13
TBVpS111.13
PEG (NY)N/A
PEG (5Y)0.84
Profitability
Industry RankSector Rank
ROA 7.14%
ROE 21.93%
ROCE 11.17%
ROIC 8.68%
ROICexc 9.8%
ROICexgc 37.81%
OM 8.16%
PM (TTM) 5.39%
GM N/A
FCFM 5.99%
ROA(3y)7.06%
ROA(5y)7.43%
ROE(3y)22.21%
ROE(5y)22.85%
ROIC(3y)10.14%
ROIC(5y)10.16%
ROICexc(3y)11.32%
ROICexc(5y)11.36%
ROICexgc(3y)32.46%
ROICexgc(5y)32.01%
ROCE(3y)13.1%
ROCE(5y)13.1%
ROICexcg growth 3Y-2.11%
ROICexcg growth 5Y-0.12%
ROICexc growth 3Y-2.38%
ROICexc growth 5Y-0.43%
OM growth 3Y-1.09%
OM growth 5Y-0.16%
PM growth 3Y-15.71%
PM growth 5Y-8.84%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 3.31
Debt/EBITDA 1.89
Cap/Depr 87.77%
Cap/Sales 0.89%
Interest Coverage 250
Cash Conversion 74.94%
Profit Quality 111.07%
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z N/A
F-Score7
WACC8.16%
ROIC/WACC1.06
Cap/Depr(3y)84.34%
Cap/Depr(5y)80.61%
Cap/Sales(3y)0.88%
Cap/Sales(5y)0.86%
Profit Quality(3y)124.43%
Profit Quality(5y)123.8%
High Growth Momentum
Growth
EPS 1Y (TTM)7.46%
EPS 3Y13.67%
EPS 5Y13.07%
EPS Q2Q%0.56%
EPS Next Y-12.93%
EPS Next 2Y0.03%
EPS Next 3Y4.28%
EPS Next 5Y8.37%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y11.65%
Revenue growth 5Y10.57%
Sales Q2Q%9.49%
Revenue Next Year12.32%
Revenue Next 2Y9.49%
Revenue Next 3Y8.71%
Revenue Next 5Y8.02%
EBIT growth 1Y3.95%
EBIT growth 3Y10.44%
EBIT growth 5Y10.4%
EBIT Next Year-3.21%
EBIT Next 3Y6.93%
EBIT Next 5Y8.55%
FCF growth 1Y-28.23%
FCF growth 3Y0.99%
FCF growth 5Y4.56%
OCF growth 1Y-24.21%
OCF growth 3Y2.39%
OCF growth 5Y5.37%